Comparison of the Efficacy of Sacral Espb and Caudal Block for Pain Management After Urogenital Surgeries in Children
NCT ID: NCT06373185
Last Updated: 2024-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2024-04-22
2024-07-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sacral Erector Spinae Plane Blocks in Pediatric Patients
NCT05415046
Transversus Abdominis Plane Block Versus Erector Spina Plane Block
NCT04095325
Ultrasound-Guided Versus Conventional Injection for Caudal Block
NCT03337191
Comparison Sacral Erector Spinae Block Versus Caudal Block
NCT04106687
Erector Spina Plane (ESP) Block in Pediatric Patients
NCT04875390
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SESPB
Participants received ultrasound-guided SESPB before the surgery
Ultrasound-guided sacral erector spinae plane block
Patients were received ultrasound-guided sacral erector spinae plane block, 1ml/kg %0.25 bupivacaine (max 20 ml), for postoperative pain management
CAUDAL
Participants received ultrasound-guided caudal block before the surgery
Ultrasound-guided caudal block
Patients were received ultrasound-guided caudal block, 1ml/kg %0.25 bupivacaine (max 20 ml), for postoperative pain management
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasound-guided sacral erector spinae plane block
Patients were received ultrasound-guided sacral erector spinae plane block, 1ml/kg %0.25 bupivacaine (max 20 ml), for postoperative pain management
Ultrasound-guided caudal block
Patients were received ultrasound-guided caudal block, 1ml/kg %0.25 bupivacaine (max 20 ml), for postoperative pain management
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients in American Society of Anesthesiologist (ASA) class I-II
Exclusion Criteria
* Patients with anatomical changes in the sacral region, previous surgery, scar and infection,
* Patients with known local anaesthetic allergy
* Patients for whom regional anaesthesia is contraindicated
* Known neurological or muscular disease
1 Year
7 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Giresun University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bilge Olgun Keles
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bilge Olgun Keleş
Role: PRINCIPAL_INVESTIGATOR
Giresun University
Dilek Yeniay
Role: STUDY_CHAIR
Giresun University
Elvan Tekir Yılmaz
Role: STUDY_CHAIR
Giresun University
İlke Tamdoğan
Role: STUDY_CHAIR
Giresun University
Mehmet Değermenci
Role: STUDY_CHAIR
Giresun University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Giresun Research and Training Hospital
Giresun, Central, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023/21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.